Search results
New mRNA vaccine for deadly brain cancer triggers a strong immune response
Live Science via Yahoo News· 1 day ago"These results represent an exciting advance in next generation cancer therapies that leverage mRNA,...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 10 hours agoAdministration (FDA) that due to administrative constraints, the agency does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna's ...
Will withdrawal of AstraZeneca vaccine affect your next COVID booster jab?
Yahoo News UK· 2 days agoWe will now work with regulators and our partners to align on a clear path forward to conclude this...
Moderna’s mRNA dreams meet reality with first post-COVID shot - The Boston Globe
The Boston Globe· 24 hours ago“The platform is working,” he said at the company’s Vaccines Day, a presentation to investors in...
Dow Jones Today: Stocks Mixed As Dow on Track To Extend Winning Streak to Eight Consecutive Sessions
Investopedia· 3 hours agoModerna (MRNA) slid 4% as the biotech’s effort to move beyond just a COVID-19 vaccine was stalled...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 15 hours agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination ...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 11 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 1 day agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....